Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
COSMOS PharmaceuticalCSMYF 93 Net Margin % is 2.96% as of Feb. 2026, which is 5% below its 10-year median of 3.10. GuruFocus rates CSMYF with a GF Score™ of 93/100 and a GF Value™ of $50.48 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 664 Healthcare Providers & Services companies, COSMOS Pharmaceutical ranks better than 50% on this metric.
The historical rank and industry rank for COSMOS Pharmaceutical's Net Margin % or its related term are showing as below:
CSMYF'
s Net Margin % Range Over the Past 10 Years
Min: 2.53 Med: 3.1 Max: 3.74
Current: 2.93
CSMYF's Net Margin % is ranked better than 50% of 664
companies
in the Healthcare Providers & Services industry
Industry Median: 2.915
vs CSMYF: 2.93
COSMOS Pharmaceutical (OTCPK:CSMYF) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
COSMOS Pharmaceutical Net Margin % Related Terms
COSMOS Pharmaceutical Net Margin % Historical Data
* Premium members only.
The historical data trend for COSMOS Pharmaceutical's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
COSMOS Pharmaceutical Net Margin % Competitor Comparison
For the Pharmaceutical Retailers subindustry, COSMOS Pharmaceutical's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
COSMOS Pharmaceutical Net Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, COSMOS Pharmaceutical's Net Margin % distribution charts can be found below:
* The bar in red indicates where COSMOS Pharmaceutical's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
COSMOS Pharmaceutical (CSMYF) has a Net Margin % of 2.96% as of Feb. 2026. Net margin is the ratio of total net income to net sales. View historical data on COSMOS Pharmaceutical and its competitors. This is near median its historical median of 3.10. Over the past decade, COSMOS Pharmaceutical's Net Margin % has ranged from 2.53 to 3.74. According to the industry distribution chart, COSMOS Pharmaceutical ranks #332 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 50%.
Is COSMOS Pharmaceutical's Net Margin % too high?
COSMOS Pharmaceutical's current Net Margin % of 2.96% is near median its 10-year median of 3.10. Over the past 10 years, this metric has ranged from a low of 2.53 to a high of 3.74. The Healthcare Providers & Services industry median Net Margin % is 2.92. COSMOS Pharmaceutical's value of 2.96% is 1.5% above this industry median. Based on the distribution chart, COSMOS Pharmaceutical ranks #332 out of 664 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, COSMOS Pharmaceutical has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does COSMOS Pharmaceutical's Net Margin % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, COSMOS Pharmaceutical ranks #332 out of 664 companies for Net Margin %. This puts COSMOS Pharmaceutical in the upper half of its industry. The industry median Net Margin % is 2.92. COSMOS Pharmaceutical's value of 2.96% is 1.5% above this benchmark. Historically, COSMOS Pharmaceutical's own Net Margin % has ranged from 2.53 to 3.74 over the past decade. While the company's 10-year median is 3.10 vs. the industry median of 2.92, COSMOS Pharmaceutical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Healthcare Providers & Services company?
The median Net Margin % among Healthcare Providers & Services companies is 2.92, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. COSMOS Pharmaceutical's current Net Margin % of 2.96% is 1.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on COSMOS Pharmaceutical and its competitors. For the Healthcare Providers & Services industry, the median Net Margin % is 2.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. COSMOS Pharmaceutical's current Net Margin % is 2.96%, which is near median its own 10-year median of 3.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is COSMOS Pharmaceutical stock overvalued right now?
Based on GuruFocus' analysis, COSMOS Pharmaceutical (CSMYF) is currently considered Modestly Undervalued. The stock's GF Value™ is $50.48, compared to a current price of $37.06 — trading 26.6% below its estimated fair value. The current Net Margin % is 2.96%, which is near median its 10-year median of 3.10 and 1.5% above the Healthcare Providers & Services industry median of 2.92. COSMOS Pharmaceutical's overall GF Score™ is 93/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For COSMOS Pharmaceutical (CSMYF), the current Net Margin % is 2.96% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is COSMOS Pharmaceutical (CSMYF) Overvalued in 2026?
Based on GuruFocus' analysis, COSMOS Pharmaceutical stock appears to be undervalued.
The current stock price of $37.06 is trading 26.6% below its estimated GF Value™ of $50.48.
GuruFocus considers COSMOS Pharmaceutical to be Modestly Undervalued.
Key valuation signals for CSMYF:
Net Margin %: 2.96% (near median its 10-year median of 3.10)
GF Value™: $50.48 vs. price of $37.06 (26.6% below fair value)
Industry Position: 1.5% above the Healthcare Providers & Services median (#332 of 664)
No single metric tells the full story. See the CSMYF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
COSMOS Pharmaceutical Corp manages retail drugstores in Japan. The company emphasizes convenience regarding its product selection, which includes medical products, health and beauty aids, personal-care items, discount cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, alcoholic beverages, tobacco, insect repellent, and miscellaneous everyday consumables. The majority of the company's revenue is derived from common grocery sales. It also operates a private grocery brand called ON 365.
93GF Score
Get the complete analysis for CSMYF
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CSMYF has been successfully added to your 
